Spanish Blood Cancer Library - Are inhibitory molecules like the programmed cell death protein 1 (PD1) and its ligand (PDL1) active in lymphoma and in chronic lymphocytic leukemia?

dbrock's picture

Submitted by dbrock on Wed, 11/15/2017 - 16:34

¿Están activos moléculas inhibitorias como el de la muerte programada 1 (PD1) y el ligando de muerte programada 1 (PDL1) en el linfoma y en la leucemia linfocítica crónica (LLC)?
Marco A. Ruiz, MD, GRACE Faculty

GRACE sat down with Dr. Marco Ruiz to discuss information regarding inhibitory molecules like the programmed cell death protein 1 (PD1) and its ligand (PDL1), and if they are active in lymphoma and in chronic lymphocytic leukemia (¿Están activos moléculas inhibitorias como el de la muerte programada 1 (PD1) y el ligando de muerte programada 1 (PDL1) en el linfoma y en la leucemia linfocítica crónica (LLC)?).  Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin).

 

We would like to thank the following company for their support of this program:

 

 

Video Language: 
Spanish

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation